Literature DB >> 21263435

Obesity in 2010: the future of obesity medicine: where do we go from here?

Suzanne M Wright1, Louis J Aronne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21263435     DOI： 10.1038/nrendo.2010.231

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  6 in total

1.  Multicenter, placebo-controlled trial of lorcaserin for weight management.

Authors:  Steven R Smith; Neil J Weissman; Christen M Anderson; Matilde Sanchez; Emil Chuang; Scott Stubbe; Harold Bays; William R Shanahan
Journal:  N Engl J Med       Date:  2010-07-15       Impact factor: 91.245

2.  Anorectics on trial: a half century of federal regulation of prescription appetite suppressants.

Authors:  Eric Colman
Journal:  Ann Intern Med       Date:  2005-09-06       Impact factor: 25.391

3.  Sibutramine in cardiovascular disease: is SCOUT the new STORM on the horizon?

Authors:  Stephan von Haehling; Mitja Lainscak; Stefan D Anker
Journal:  Eur Heart J       Date:  2007-11-05       Impact factor: 29.983

4.  Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

Authors:  Frank L Greenway; Ken Fujioka; Raymond A Plodkowski; Sunder Mudaliar; Maria Guttadauria; Janelle Erickson; Dennis D Kim; Eduardo Dunayevich
Journal:  Lancet       Date:  2010-07-29       Impact factor: 79.321

5.  Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects.

Authors:  W Philip T James; Ian D Caterson; Walmir Coutinho; Nick Finer; Luc F Van Gaal; Aldo P Maggioni; Christian Torp-Pedersen; Arya M Sharma; Gillian M Shepherd; Richard A Rode; Cheryl L Renz
Journal:  N Engl J Med       Date:  2010-09-02       Impact factor: 91.245

Review 6.  Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.

Authors:  Harold Bays
Journal:  Expert Rev Cardiovasc Ther       Date:  2010-08-16
  6 in total
  7 in total

Review 1.  Potential use of exenatide for the treatment of obesity.

Authors:  Franco Folli; Rodolfo Guardado Mendoza
Journal:  Expert Opin Investig Drugs       Date:  2011-10-24       Impact factor: 6.206

2.  Design, synthesis, structural and functional characterization of novel melanocortin agonists based on the cyclotide kalata B1.

Authors:  Rasmus Eliasen; Norelle L Daly; Birgitte S Wulff; Thomas L Andresen; Kilian W Conde-Frieboes; David J Craik
Journal:  J Biol Chem       Date:  2012-09-25       Impact factor: 5.157

3.  Mogroside-Rich Extract From Siraitia grosvenorii Fruits Ameliorates High-Fat Diet-Induced Obesity Associated With the Modulation of Gut Microbiota in Mice.

Authors:  Siyuan Wang; Kexin Cui; Jiahao Liu; Jiahao Hu; Ke Yan; Peng Xiao; Yangqing Lu; Xiaogan Yang; Xingwei Liang
Journal:  Front Nutr       Date:  2022-06-13

4.  Myths, presumptions, and facts about obesity.

Authors:  Krista Casazza; Kevin R Fontaine; Arne Astrup; Leann L Birch; Andrew W Brown; Michelle M Bohan Brown; Nefertiti Durant; Gareth Dutton; E Michael Foster; Steven B Heymsfield; Kerry McIver; Tapan Mehta; Nir Menachemi; P K Newby; Russell Pate; Barbara J Rolls; Bisakha Sen; Daniel L Smith; Diana M Thomas; David B Allison
Journal:  N Engl J Med       Date:  2013-01-31       Impact factor: 91.245

Review 5.  Contribution of common non-synonymous variants in PCSK1 to body mass index variation and risk of obesity: a systematic review and meta-analysis with evidence from up to 331 175 individuals.

Authors:  Kevin T Nead; Aihua Li; Mackenzie R Wehner; Binod Neupane; Stefan Gustafsson; Adam Butterworth; James C Engert; A Darlene Davis; Robert A Hegele; Ruby Miller; Marcel den Hoed; Kay-Tee Khaw; Tuomas O Kilpeläinen; Nick Wareham; Todd L Edwards; Göran Hallmans; Tibor V Varga; Sharon L R Kardia; Jennifer A Smith; Wei Zhao; Jessica D Faul; David Weir; Jie Mi; Bo Xi; Samuel Canizales Quinteros; Cyrus Cooper; Avan Aihie Sayer; Karen Jameson; Anders Grøntved; Myriam Fornage; Stephen Sidney; Craig L Hanis; Heather M Highland; Hans-Ulrich Häring; Martin Heni; Jessica Lasky-Su; Scott T Weiss; Glenn S Gerhard; Christopher Still; Melkaey M Melka; Zdenka Pausova; Tomáš Paus; Struan F A Grant; Hakon Hakonarson; R Arlen Price; Kai Wang; Andre Scherag; Johannes Hebebrand; Anke Hinney; Paul W Franks; Timothy M Frayling; Mark I McCarthy; Joel N Hirschhorn; Ruth J Loos; Erik Ingelsson; Hertzel C Gerstein; Salim Yusuf; Joseph Beyene; Sonia S Anand; David Meyre
Journal:  Hum Mol Genet       Date:  2015-03-17       Impact factor: 6.150

6.  Evaluation of AMG 076, a potent and selective MCHR1 antagonist, in rodent and primate obesity models.

Authors:  Alykhan S Motani; Jian Luo; Lingming Liang; Jeffrey T Mihalic; Xiaoqi Chen; Liang Tang; Leping Li; Juan Jaen; Jin-Long Chen; Kang Dai
Journal:  Pharmacol Res Perspect       Date:  2013-09-17

7.  Intestinal removal of free fatty acids from hosts by Lactobacilli for the treatment of obesity.

Authors:  Hea-Jong Chung; Jae G Yu; In-Ah Lee; Ming-Jie Liu; Yan-Fei Shen; Satya P Sharma; Mohammad A H M Jamal; Jun-Hyun Yoo; Hyeon-Jin Kim; Seong-Tshool Hong
Journal:  FEBS Open Bio       Date:  2016-01-18       Impact factor: 2.693
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.